| MONDAY OCTOBER 13th |
14:00-17:00 | Registration |
17:00 | Welcome and opening remarks |
17:15 | Opening Keynote Lecture |
Normal and neoplastic stem cells | Irving L. WEISSMAN (Stanford University, USA) |
18:15-19:45 | Reception and Poster Session |
TUESDAY OCTOBER 14 |
8:00-9:00 | Registration |
9:00-10:40 | Session I: Cell Fate Choices and Reprogramming |
| Novel strategies for cellular reprogramming | Hongkui DENG (Center for Life Sciences, Peking University, Beijing, China) |
| Human cellular models of CNS disease and evolution | Fred H. GAGE (Salk Institute for Biological Studies, La Jolla, USA) |
| Somatic reprogramming and embryonic development | Jinsong LI (Shanghai Institute for Biological Sciences, Chinese Academy of Science,Shanghai, China) |
| In vivo generation of functional cells and organs from iPSCs | Hiromitsu NAKAUCHI (Stanford University, Stanford, USA) |
10:40-11:10 | Coffee Break |
11:10-12:50 | Session II: Animal Models |
| Basic research and potential application of stem cells: Cell banks and animal models | Qi ZHOU (Institute of Zoology, Chinese Academy of Science, Beijing, China) |
| Stem Cell and Transgenic Animal | Lei XIAO (Zhejiang University, Zhejiang, China) |
| Modeling neurological and psychiatric disorders with iPSCs technologies and transgenic non-human primates | Hideyuki OKANO (Keio University, Keio, Japan) |
| Gene targeting in monkeys with TALEN and CRISPR/Cas9 | Weizhi JI (Yunnan Key Laboratory of Primate Biomedical Research,Kunming, China) |
12:50-14:00 | Lunch |
14:00-15:40 | Session III: Organs and Regeneration |
| Translating stem cells to the treatment of life-threatening liver disease | Ira J.FOX (University of Pittsburgh, Pittsburgh, USA) |
| Engineering pluripotent stem cell microenvironments for directed morphogenesis | Todd McDEVITT (Georgia Institute of Technology, Atlanta, USA) |
| Making pancreatic beta cells from stem cells | Maike SANDER (University of California SD, San Diego, USA) |
| Immune regulation of tissue regeneration | Nadia ROSENTHAL (Imperial College, London, UK) |
15:40-16:00 | Coffee Break |
16:00-17:30 | Session IV: Panel Discussion |
| International guidelines for stem cell therapies | Michele De Luca，Fred H. GAGE, Christine L. MUMMERY, Nadia ROSENTHAL，Irving L. WEISSMAN, Qi Zhou |
WEDNESDAY OCTOBER 15 |
8:45-9:45 | Keynote Lecture |
| Human pluripotent stem cells as models of cardiovascular disease | Christine L. MUMMERY (Leiden University Medical Centre, Leiden, The Netherlands) |
9:45-10:00 | Coffee Break |
10:00-12:05 | Session V: Translational and Clinical Applications |
| Early clinical trial results in spinal cord injury and age-related macular degeneration | Ann TSUKAMOTO (Stem Cells Inc., Newark, USA) |
| The challenges of translating bioactive scaffolds for tendinopathies into the clinic | Andrew Carr (University of Oxford, London, England ) |
| Epithelial stem cells in cell and gene therapy | Michele de Luca (University of Modena, Italy) |
| A big Pharma perspective on cell therapies | Mark ZIMMERMAN (Janssen Research & Development, LLC ) |
| Creating health and wealth through cell therapy translation | Keith THOMPSON (Catapult, London, UK) |
12:10-13:20 | Lunch |
13:20 -15:00 | 13:20 -15:00 Session VI: New Tools and Techniques |
| Development and applications of CRISPR-Cas9 for genome biology | Feng ZHANG (Broad Institute of MIT and Harvard, Cambridge, USA) |
| Tissue mechanics from a stem cell perspective | Dennis E. DISCHER (University of Pennsylvania, Philadelphia, USA) |
| The biomechanics of tissue architecture and plasticity: Concepts and tools | Thomas LECUIT (Aix-Marseille Université, Marseille, France) |
| Long-term single stem cell quantification: New tools for old questions | Timm SCHROEDER (ETH Zurich, Basel, Switzerland) |
15:00-15:15 | Coffee Break |
15:15-16:30 | Session VII: Panel Discussion |
| Chair: Mark ZIMMERMAN |
| Translational obstacles to stem cell therapy implementation | Panelists: Mark ZIMMERMAN, Keith THOMPSON, Ira J. FOX, Ann TSUKAMOTO |
16:30 | Closing Remarks |
